Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Replacing cells in multiple sclerosis.

Ian D Duncan1

  • 1Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53706, USA. duncani@svm.vetmed.wisc.edu

Journal of the Neurological Sciences
|June 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A canine <i>PLP1</i> missense variant differentiates oligodendrocyte maturation in connatal and classical Pelizaeus-Merzbacher disease.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

QSI and DTI of Inherited White Matter Disorders in Rat Spinal Cord: Early Detection and Comparison with Quantitative Electron Microscopy Findings.

Diagnostics (Basel, Switzerland)·2025
Same author

Promotion of remyelination by a thyromimetic drug leading to functional recovery.

Experimental neurology·2025
Same author

Pathologic classification of a late-onset peripheral neuropathy in a spontaneous Labrador retriever dog model.

The Journal of comparative neurology·2024
Same author

Wobbly hedgehog syndrome- a progressive neurodegenerative disease.

Experimental neurology·2023
Same author

Wobbly hedgehog syndrome- a progressive neurodegenerative disease.

bioRxiv : the preprint server for biology·2023
Same journal

Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

Journal of the neurological sciences·2026
Same journal

Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

Journal of the neurological sciences·2026
Same journal

Time-resolved GluCEST MRI of acute glutamate-related signal changes following kainic acid administration.

Journal of the neurological sciences·2026
Same journal

Sex differences in brain frailty measures and outcomes after endovascular thrombectomy: ESCAPE-NA1 analysis.

Journal of the neurological sciences·2026
Same journal

Neurophobia in context: Demographic and mental health correlates.

Journal of the neurological sciences·2026
Same journal

Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.

Journal of the neurological sciences·2026
See all related articles

Cell transplantation offers hope for neurodegenerative diseases like multiple sclerosis (MS). Research focuses on replacing lost oligodendrocytes to remyelinate axons and prevent disability, using stem cell-derived cells for future therapies.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Neurodegenerative diseases, including multiple sclerosis (MS), present significant therapeutic challenges.
  • Axonal degeneration and loss in MS lead to chronic disability.
  • Oligodendrocyte loss during MS relapses necessitates remyelination strategies.

Purpose of the Study:

  • To explore cell transplantation as a therapeutic strategy for neurodegenerative diseases, particularly MS.
  • To investigate methods for remyelinating axons and protecting them from degeneration in MS.
  • To establish a source of human oligodendrocytes for translational applications.

Main Methods:

  • Isolation and purification of human oligodendrocytes from neural or embryonic stem cells.
  • Developing strategies for exogenous cell delivery to repair MS lesions.

Related Experiment Videos

  • Stimulating endogenous oligodendrocyte progenitor differentiation.

    • Main Results:

    • Successful isolation and purification of human oligodendrocytes from stem cells.
    • Potential for generating sufficient cell numbers for clinical use.
    • Identification of cell transplantation as a viable approach for MS treatment.

    Conclusions:

    • Cell transplantation is a promising therapeutic avenue for neurodegenerative diseases like MS.
    • Stem cell-derived oligodendrocytes offer a potential solution for remyelination.
    • Future strategies involve targeted lesion repair and widespread cell delivery.